Achelios Therapeutics
Finance and operations leader who enjoys building corporate performance and financial excellence through financial leadership, operational discipline, and strategic planning. Skilled at formulating and implementing business strategies, growth initiatives, and process improvements that drive top and bottom-line growth.
Data driven, hands on, collaborative leader, who builds high performing teams, based on trust and accountability, to drive better business outcomes. Trusted advisor to the CEO, senior leadership teams and Board of Directors with a wide range of experience working with venture-backed start ups, growth companies, mature businesses and turnaround situations, raising capital, expanding businesses, buying and selling companies, improving processes, optimizing portfolio profitability and implementing management operating systems focused on delivering value to employees, customers and shareholders.
This person is not in any offices
Achelios Therapeutics
Achelios Therapeutics’ lead reformulation product, TOPOFEN™, pairs its proprietary ACHETOGEL™ delivery technology with the proven NSAID ketoprofen. In pre-clinical and early-stage clinical studies, they have shown TOPOFEN™ (ketoprofen) to provide superior tissue penetration compared to other topical formulations currently on the market.